Medical College of Wisconsin executive VP and dean of medical school to step down by the end of the year Milwaukee Journal Sentinel Nawigacja wpisu Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial – Nature.com UChicago Medicine and Pritzker School of Medicine | Newswise – Newswise
